Targeting PARP inhibitor resistance with Polθ inhibitors

被引：0

作者：

Zatreanu, Diana ^{[1
]}

Robinson, Helen ^{[2
]}

Alkhatib, Omar ^{[2
]}

Boursier, Marie ^{[2
]}

Finch, Harry ^{[2
]}

Geo, Lerin ^{[2
]}

Grande, Diego ^{[2
]}

Grinkevich, Vera ^{[2
]}

Heald, Robert ^{[2
]}

Langdon, Sophie ^{[2
]}

Majithiya, Jayesh ^{[2
]}

McWhirter, Claire ^{[2
]}

Martin, Niall ^{[2
]}

Moore, Shaun ^{[2
]}

Neves, Joana ^{[2
]}

Rajendra, Eeson ^{[2
]}

Ranzani, Marco ^{[2
]}

Schaedler, Theresia ^{[2
]}

Stockley, Martin ^{[2
]}

Wiggins, Kimberley ^{[2
]}

Brough, Rachel ^{[1
]}

Sridhar, Sandhya ^{[1
]}

Gulati, Aditi ^{[1
]}

Shao, Nan ^{[1
]}

Badder, Luted ^{[1
]}

Novo, Daniela ^{[1
]}

Knight, Eleanor ^{[1
]}

Marlow, Rebecca ^{[1
]}

Haider, Syed ^{[1
]}

Callen, Elsa ^{[3
]}

Hewitt, Graeme ^{[4
]}

Schimmel, Joost ^{[5
]}

Prevo, Remko ^{[6
]}

Alli, Christina ^{[7
]}

Ferdinand, Amanda ^{[7
]}

Bell, Cameron ^{[7
]}

Blencowe, Peter ^{[7
]}

Bot, Chris ^{[7
]}

Calder, Mathew ^{[7
]}

Charles, Mark ^{[7
]}

Curry, Jayne ^{[7
]}

Ekwuru, Tennyson ^{[7
]}

Nussenzweig, Andre ^{[3
]}

Tijsterman, Marcel ^{[5
]}

Tutt, Andrew N. ^{[1
]}

Boulton, Simon ^{[4
]}

Higgins, Geoff ^{[6
]}

Pettitt, Stephen J. ^{[1
]}

Smith, Graeme C. ^{[2
]}

Lord, Christopher J. ^{[1
]}

机构：

[1] Inst Canc Res, London, England

[2] Artios Pharma, Cambridge, England

[3] NCI, NIH, Bethesda, MD USA

[4] Francis Crick Inst, London, England

[5] Leiden Univ, Med Ctr, Leiden, Netherlands

[6] Med Res Council Oxford Inst Radiat Oncol, Oxford, England

[7] CRUK Therapeut Discovery Labs, Cambridge, England

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5697

引用

页数：1

共 50 条

[21] A review on mechanisms of resistance to PARP inhibitors
Desai, Chirag
Pathak, Anand
Limaye, Sewanti
Maniar, Vashishth
Joshi, Archita
[J]. INDIAN JOURNAL OF CANCER, 2022, 59 : S119 - S129
[22] Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells
Barszczewska-Pietraszek, Gabriela
Czarny, Piotr
Drzewiecka, Malgorzata
Blaszczyk, Maciej
Radek, Maciej
Synowiec, Ewelina
Wigner-Jeziorska, Paulina
Sitarek, Przemyslaw
Szemraj, Janusz
Skorski, Tomasz
Sliwinski, Tomasz
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
[23] Targeting DNA Repair in Cancer : Beyond PARP Inhibitors
Brown, Jessica S.
O'Carrigan, Brent
Jackson, Stephen P.
Yap, Timothy A.
[J]. CANCER DISCOVERY, 2017, 7 (01) : 20 - 37
[24] PARP inhibitor resistance in prostate cancer.
D'Andrea, Alan D.
[J]. CANCER RESEARCH, 2018, 78 (16) : 20 - 21
[25] Dissecting PARP inhibitor resistance with functional genomics
Pettitt, Stephen J.
Lord, Christopher J.
[J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2019, 54 : 55 - 63
[26] Overcoming PARP inhibitor resistance in ovarian cancer
Pina, Pamela Soberanis
Lheureux, Stephanie
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 364 - 376
[27] -003 Oxygen dependent resistance to PARP inhibitors
Mehibel, Manal
Xu, Jimmy
Li, Grace
Moon, Jung
Thakkar, Kaushik
Diep, Anh
Kim, Ryan
Blomstein, Joshua
Xiao, Siren
Bacal, Julien
Saldivar, Joshua
Le, Quynh
Cimprich, Karlene
Rankin, Erinn
Giaccia, Amato
[J]. CLINICAL CANCER RESEARCH, 2021, 27 (08)
[28] AsiDNA abrogates acquired resistance to PARP inhibitors
Jdey, Wael
Lascaux, Pauline
Bono, Francoise
[J]. CANCER RESEARCH, 2019, 79 (13)
[29] Mechanisms of PARP inhibitor resistance in ovarian cancer
Kubalanza, Kari
Konecny, Gottfried E.
[J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (01) : 36 - 41
[30] Strategies for the prevention or reversal of PARP inhibitor resistance
Mitri, Zahi
Goodyear, Shaun M.
Mills, Gordon
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2024,

← 1 2 3 4 5 →